The LSGSA hopes this email finds you well! 
We would like to share information with you about the ILF
(International Lymphoedema Framework) Chronic Oedema Outcomes Measure survey -
if you have not yet had the chance to participate there is still time. 
Open to
Consumers, Health Professionals and Industry, it only takes a few minutes and
the findings will be used to help improve patient outcomes!  Warm Regards,
LSGSA :)
 International Lymphoedema Framework Chronic Oedema Outcome Measure
 
  | 
  
   
    | 
     
      | 
 | 
       
        | INVITATION to participate in ILF international
        study on Chronic Oedema Outcome Measure 
 The Chronic Oedema Outcome
        Measure (ILF-COM) project is aiming to develop an internationally
        agreed set of outcome measures for patients with chronic
        oedema. As part of this project, the ILF is conducting an
        international survey. We invite patients, health care
        professionals and industry representatives worldwide to take part in
        this survey which can be accessed via this link:
 
 https://www.surveymonkey.com/r/CYSCKKT
 
 Undertaking the
        international survey serves several purposes including identifying:
 The range of outcome measures used in different
             countries and how these are viewed by the reimbursement and/or
             health care systems.
 The issues that are important to patients as
             outcomes of care.
 The challenges faced by the medical device
             industry in gaining reimbursement of products.
 Your input is important to
        help us understand the effects of lymphoedema treatment. With this
        information we would hope to set international standards. Read
        more about the ILF-COM project here.Outcome measures appropriate for use by
             reimbursement and health agencies, and for use in chronic oedema
             research.
 |  |  |  |  |